Life Science REIT Secures Seven-Year Lease Renewal with Thought Machine at Herbrand Street

Life Science REIT secures 7-year lease renewal with Thought Machine at Herbrand Street, locking in income at ERV with lender support. A positive step for income visibility.

9 September 2025by Joshua Thompson5 min read61 views

This article covers information on Life Science REIT PLC.

LON:LABS

Seven-year lease renewal at Herbrand Street locks in income and validates rental tone

Life Science REIT has secured a fresh seven-year lease with Thought Machine at Herbrand Street in London’s Knowledge Quarter, keeping the FinTech firm as the sole occupier. The headline rent is £75.0 per sq ft, which is in line with the June 2025 estimated rental value (ERV) – a useful confirmation of market rents for this asset.

The lease includes an upward-only rent review after the fourth year and a 16.5 month rent-free period. The agreement has been signed with the Company’s lending banks, who remain supportive.

What the lease terms tell us about cash flow, value and risk

On the face of it, this is exactly what investors want to see: a core, fully-let London asset with a committed occupier for seven years. No voids, no dilapidations battle, and no reletting risk in a less certain office market. The headline rent matching ERV is particularly interesting – it implies valuers have the pricing about right and there has been no need to discount to keep the tenant.

The incentive is chunky at 16.5 months rent free, but for a seven-year term that is not out of line. On a straight-line basis, 16.5 months out of 84 months equates to a 19.6% concession over the initial term. That puts a simple average effective rent around £60.27 per sq ft before any uplift at the year-four review, and ignoring the time value of money. In plain English: the cash collected will be lower than the headline in the early period but should normalise after the incentive burns off.

Key numbers and terms to know

Tenant	Thought Machine Group Limited
Building	Herbrand Street, Grade II listed
Lettable area	68,600 sq ft
Lease length	Seven years
Headline rent	£75.0 per sq ft (in line with June 2025 ERV)
Rent review	Upward-only after the fourth year
Incentive	16.5 month rent-free period
Occupancy	Sole occupier retained
Lenders	Agreement obtained; banks remain supportive

Implied headline annual rent is approximately £5.15 million (68,600 sq ft at £75.0 per sq ft). This is a simple derivation from disclosed figures – the Company has not disclosed an annual rent figure.

Why this matters for Life Science REIT shareholders

Income visibility improves. Extending for seven years anchors cash flows from a central London asset and reduces near-term leasing risk. With an upward-only review after year four, the rent cannot go down on review, which helps protect the income line in an uncertain market.

Share𝕏 in

Investing
Polar Capital Technology Trust Reports 102% NAV Growth in Stellar Fiscal Year
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Investing

Tagged

Last updated

5 July 2026

Star Rating

No ratings yet

Valuation support is evident. Securing a deal at ERV suggests the building’s carrying value is underpinned by real transactions, not just valuer theory. That is not trivial in a market where office yields and rental assumptions are being tested.

Lender confidence is notable. The RNS explicitly says the lease was agreed with the Company’s lending banks, who continue to be supportive. That reads as a green light from debt providers on covenant headroom and business plan execution at this asset.

Context: Herbrand Street’s role in the LABS portfolio

Herbrand Street is a 68,600 sq ft, Grade II listed building acquired in May 2022. It sits in the Knowledge Quarter near UCL, UCH and Great Ormond Street Hospital – prime demand drivers for knowledge industries. While Thought Machine is FinTech rather than wet-lab life sciences, it still fits the knowledge-economy theme and underlines the broader demand for high-quality space in this micro-market.

Life Science REIT’s strategy spans development through to fully let assets, with a focus on addressing lab-space scarcity across the Golden Triangle. Keeping a landmark London asset fully occupied while the group advances lab conversion and development elsewhere helps balance income stability with growth projects.

The good, the less good, and the watchlist

Positives I see

Seven-year commitment from an established occupier reduces void risk and reletting costs.
Rent set at ERV confirms market pricing and helps underpin valuation assumptions.
Upward-only review post year four provides downside protection on future rent.
Explicit lender support lowers perceived financing risk around this asset.
Maintains 100% occupancy at a prime Knowledge Quarter address.

Trade-offs and risks to keep in mind

Rent-free incentive is meaningful, which dilutes early cash receipts relative to the headline rent.
Single-tenant exposure creates concentration risk – if the tenant were to leave at expiry, reletting the entire building would be a project. No break options are disclosed.
Grade II listing can constrain alterations and may increase capex complexity, although it also supports the building’s prestige and tenant appeal.
FinTech is not the core lab end-market; while firmly in the knowledge economy, it does not directly absorb lab space.

Crunching the numbers: a quick back-of-the-envelope

To frame the incentive, the 16.5 month rent-free over 84 months equates to a 19.6% headline discount over the initial term. On a simple average basis, that puts the effective rent around £60.27 per sq ft before the year-four review. Applied to 68,600 sq ft, that’s roughly £4.14 million per year on a straight-line basis, again before any review uplift and ignoring discount rates.

Accounting treatment is not disclosed, but UK property companies often recognise rental income on a straight-line basis over the lease term after incentives. Cash receipts will be lower during the rent-free period, then step up to the £75.0 per sq ft headline thereafter unless adjusted at review.

My take: a sensible, de-risking move in a core location

This is a tidy outcome. Life Science REIT keeps a quality Knowledge Quarter building fully occupied at market rent with a seven-year runway and an upward-only review baked in. Yes, the incentive is sizeable, but in exchange the Company trades time for certainty – a fair deal in today’s market.

The explicit nod from lending banks is the cherry on top, signalling supportive debt counterparties. Overall, I would mark this announcement as incrementally positive for income visibility and valuation support at the portfolio’s London core.

What to watch next

Any disclosure on net effective rent and the impact on near-term rental income – not disclosed today.
Outcome of the year-four rent review and evidence of rental growth in the Knowledge Quarter.
Further progress on lab conversions and developments across the Golden Triangle to complement this steady income asset.